QA: AbCellera Biologics Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001703057_2023_AbCellera_Biologics_Inc.pdf

Logs

Graph

Absolute values for 0001703057, AbCellera Biologics Inc.

  xvar xval
0 AssetsCurrent 1,025,491,000
1 IntangibleAssetsNetIncludingGoodwill 179,308,000
2 PropertyPlantAndEquipmentNet 217,255,000
3 remainder_Assets 118,853,000
4 LiabilitiesCurrent 118,320,000
5 LiabilitiesNoncurrent 189,310,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 55,485,000
9 ResearchAndDevelopmentExpense 107,879,000
10 remainder_Expenses 186,129,000
11 remainder_Revenues 485,424,000
12 remainder_NetIncome 22,588,000
13 remainder_ComprehensiveNetIncome -1,671,000
  yvar yval
0 Assets 1,540,907,000
1 Liabilities 307,630,000
2 Expenses 349,493,000
3 Revenues 485,424,000
4 StockholdersEquity 1,233,277,000
5 NetIncome 158,519,000
6 ComprehensiveNetIncome 157,683,500
7 BaseVar 1,353,856,500
8 EconomicCapitalRatio 2.47

Edgar->Model Mapping

Feature Distribution

Change over Time